AMLODIPIN VALSARTAN Mepha Teva 10/160mg 28 pce

7680658010113 CH-65801 C09DB01 02.07.2.

Reimbursement limitations:

AMLVALMEPTEV

Le traitement combiné d' Amlodipin Valsartan Mepha Teva et d'un antagoniste du calcium I.T. 02.06 …

AMLODIPIN VALSARTAN Mepha Teva 10/160mg 28 pce
AMLODIPIN VALSARTAN Mepha Teva 10/160mg 28 pce
AMLODIPIN VALSARTAN Mepha Teva 10/160mg 28 pce
1 / 3
google

Details

Product number
6580103
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
valsartanum 160 mg, amlodipinum 10 mg ut amlodipini besilas 13.9 mg, cellulosum microcristallinum, povidonum K 29-32, carmellosum natricum conexum, cellulosum microcristallinum, talcum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, pro compresso obducto, natrium 1.53 mg.

Articles (1)

Amlodipin-Valsartan-Mepha Teva 10/160 mg, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
20/07/2023
Patient information leaflet
Français
20/07/2023
Patient information leaflet
Italien
20/07/2023
Professional SmPC
Allemand
20/07/2023
Professional SmPC
Français
20/07/2023
Professional SmPC
Italien
20/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
160.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
13.9 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
1.53 MG Substance HBESI

Reimbursement information

Public price
CHF 31.10
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2020

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
65801
Drug name
Amlodipin-Valsartan-Mepha Teva, Filmtabletten
Galenic form
FILM
ATC Code
C09DB01
Authorization status
Z
Dispensation category
B
First authorization
03/04/2017
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Essentielle Hypertonie

Packaging details

Description (FR)
AMLODIPIN VALSARTAN Mepha Teva 10/160mg 28 pce
Description (DE)
AMLODIPIN VALSARTAN Mepha Teva 10/160mg 28 Stk
Market launch
03/04/2017
Narcotic (BTM)
No

Original drug

Exforge, Filmtabletten
CHF 36.60
View original

Other packaging sizes

AMLODIPIN VALSARTAN Mepha Teva 5/80mg 28 pce
28 TABL
View
AMLODIPIN VALSARTAN Mepha Teva 5/80mg 98 pce
98 TABL
View
AMLODIPIN VALSARTAN Mepha Teva 5/160mg 28 pce
28 TABL
View
AMLODIPIN VALSARTAN Mepha Teva 5/160mg 98 pce
98 TABL
View